Stay updated on ADG126 + Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedAdded revision: v3.5.2 and removed revision: v3.5.0 from the record history.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedAdded Revision: v3.5.0 and deleted Revision: v3.4.3 in the Record History.SummaryDifference0.1%

- Check40 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the study record history.SummaryDifference0.1%

- Check69 days agoChange DetectedThe history shows a new site revision v3.4.2 added, and the government funding notice as well as the v3.4.1 revision entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check76 days agoChange DetectedAdded a government funding lapse notice with operating status guidance. Updated the site revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.8%

- Check83 days agoChange DetectedThe changes are primarily UI/formatting updates: the glossary display is now shown, and color-coded highlights indicate additions (green) and deletions (red), along with updated revision labeling. These adjustments do not alter core study data, eligibility, or results on the page.SummaryDifference1%

Stay in the know with updates to ADG126 + Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.